Board member and Chairman of Compensation Committee, GAM Holding Ltd., Switzerland (2009 - 2015)
Education
Awarded Diploma in Law Studies, Graduated with distinction (magna cum laude), Switzerland (1979 - 1985)
Awarded Bachelor of Arts degree (Ancient Greek and Latin), Rämibühl
College, Switzerland (1973 - 1979)
Attachments
Original Link
Original Document
Permalink
Disclaimer
Cosmo Pharmaceuticals NV published this content on 17 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 April 2023 05:06:04 UTC.
Cosmo Pharmaceuticals N.V. is a pharmaceutical company. The Company is focused on gastrointestinal (GI) diseases and dermatology. Its development pipeline is focused on Bowel Diseases, Colon Infections, and products to reduce the incidence of Colorectal Cancer (CRC) by increasing the detection of cancerous and pre-cancerous lesions during colonoscopy. Products which it has developed include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo for the treatment of travellersâ diarrhoea (TD), Methylene Blue MMX, which is a new diagnostic drug to improve precancerous and cancerous lesion detection during colonoscopy and Winlevi for the treatment of acne. Its therapeutic focus is on the oral and endoscopic treatment of colon diseases.